PHORA – Pulmonary Hypertension Outcome Risks Assessment

Objectives

Personalized Prognostic

To provide personalized prognostic tools for physicians and patients for survival and adverse events associated with pulmonary hypertension management.

Manage Workflow

To assist the clinical decision making team in managing patient progression.

Assist Patients

To assist the patients and their families to work with their doctors to navigate the difficult decisions associated with pulmonary hypertension.

PHORA: Pulmonary Hypertension Outcomes Risk Assessment

Why PHORA?

PHORA is designed to improve the stratification and management of pulmonary hypertension patients using a user-friendly design and advanced data mining and machine learning methods.

Who is PHORA for?

PHORA is for pulmonary hypertension physicians and their medical teams to help facilitate the decision-making process during the patient’s treatment.

Our Team

Our team consists of some of the world’s leading researchers and specialists in PH and data science.

What's New

23 Jun 2023

Article in CHEST: Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy? Insight From the AMBITION Trial

8 Nov 2022

AHA 2022: Identification of Novel Right Ventricular Function Phenotypes in Pulmonary Arterial Hypertension Using Unbiased K-Means Clustering.

17 Oct 2022

Presentation at CHEST Annual Meeting 2022: Comparison Between Pulmonary Arterial Hypertension (PAH) Risk Assessment Methods, Including Pulmonary Hypertension Outcome Risks Assessment (PHORA)